Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
We are days away from the realization (of none MDCL share holders) that MDCL is the gold standard of the cannabis world. Once these deals become finalized and actual revenue numbers get released, there will be no stopping the upward trend for this company. It won't be like a rocket ship but a slow steady upward movement with an occasional pop. In my opinion, we could see a year end price near $7.00 with a price target of $20.00 - $25.00 by June 2020.
Just an excited time to be a shareholder of MDCL right now. GLTA.
Just a funny gut feeling that we could see our first profitable quarter especially if they have sales of the new line of chocolate. If that happens, we could see a move up a few dollars due to the low float. Keeping fingers crossed.
We are 3 weeks away from the earnings report. This one should be interesting and could be the catalyst for an uptrend. We could see a nice POP. Good luck to all!
While I never like to see the amount of authorized shares to increase to 250,000,000 especially while they haven't used the total amount of 90,000,000, it doesn't mean they will use them. It just gives them the flexibility to use them if some incredible deal presents itself in the future.
I have held many companies that have increased their authorized float and have never used them. It just gives you a hint that Andy might have more potential deals lined up and wants to be prepared if they can get them to work out.
GLTA
We are all a little edgy wanting to see this stock begin its uptrend but be patient.
We are in a period of quiet time while MDCL gets the final "I's" dotted and "T's" crossed to finalize the deals. This is not unusual for completing deals and we have an incredible amount of them coming soon.
Also, things to consider are there certain parts of business overlap with the deals that can be trimmed to even add more profitability before finalizing the deals (example: like 2 retail stores too close to each other)?
When the deals are completed, will the companies be rebranded (named) under the Medicine Man name umbrella to show a mega giant company so the public will know it is one company?
Like many of you, I have never been so excited about owning a stock like this one in my 40+ years of investing. The big pop to the upside will happen when we least expect it (Federal government making cannabis legal) and then we can start planning a big party.
Good luck to all.
FIFG is now selling chocolate on their new website
https://southeastedibles.com/
Definitely moving in the right direction
I would expect MDCL to be quiet on the news front for the next few weeks/months. The only press releases you should expect is the completion of the deals already in place or earnings releases. While these deals are working to be finalized, the company has to be in a quiet mode to not jeopardize anything. The stock price swings will follow the cannabis sector related stocks in the meantime. If the cannabis stocks make a nice rally, it will certainly added some fuel to the fire once the deals finalize and earnings come out.
Dilution would be the company selling stock to fund operations. FIFG has not been doing that. That is one of the reasons I am excited about this company. The stock has been in a downturn because the cannabis sector has been in a downtrend and it is just following the sector.
Yes, trading penny stocks can be frustrating and not for the faint of heart. I really respect the management of FIFG, that don't put out puff press releases to try to push the price. The management just puts out realistic news releases when necessary and is running the company on revenues only and not issuing stock to pay bills. The low share float will be the catalyst when some really good news comes out and we could see the price run to $5.00 - $10.00.
Not many people follow this stock but it is only a matter of time before it gets noticed.
There are basically two reasons why we don't have the big boys (hedge/mutual funds) coming after this stock at this point.
First is the legalization of cannabis/marijuana federally. The funds have to worry about their shareholders who are against investing in cannabis since it is still not legal in every state across the country. I believe legalization is coming soon and that should hold off hesitation in investing in MDCL.
Second is that giant hedge/mutual funds don't invest in stocks under $5 (considered penny stock status). When the price breaks and hold above $5, the funds that aren't worried about the legalization status, will start jumping on board and giving it some fuel to take off.
It is frustrating that MDCL isn't above $5 yet, but it will get there. I wrote many weeks ago on this board that the pace MDCL is taking over companies will slow investors/funds to accumulate stock until they can digest the deals to see how dilutive or profitable they will be since none of these companies are held publicly and being able to see the financials of the acquisitions. For a company like Dye Capital to invest in MDCL, gives us validation that this is the real deal.
I believe Andy Williams is a pioneer in this industry and has had this acquisition plan in the works for a long time and was waiting for the changing of some of the laws to make this work. It is my opinion that MDCL will juggernaut and gold standard of the cannabis/marijuana industry that all the others will look to turn and copy in the future.
Medicine Man Technologies Highlights Landmark Consolidation Strategy To Create One Of North America's Largest Vertically Integrated Cannabis Operators. Projected Annual Revenues From The Previously Disclosed Proposed Acquisitions Total Approximately $170 Million In 2019
PR Newswire
DENVER, Sept. 16, 2019
DENVER, Sept. 16, 2019 /PRNewswire/ -- Medicine Man Technologies, Inc. (OTCQX: MDCL) ("Medicine Man Technologies" or the "Company") announced a culmination of its roll-up strategy today that would solidify the Company as one of the largest vertically integrated cannabis operators in North America upon closing of these pending acquisitions—and as a deeply experienced retailer and manufacturer of cannabis-infused products and concentrates driven by a leadership team that has unprecedented experience in regulated cannabis markets.
As previously disclosed, the Company—which also includes a new executive team with decades of experience in mergers & acquisitions, private equity, strategic operations and corporate finance—has entered into binding term sheets to acquire some of the best-selling cannabis brands in the legal Colorado cannabis industry, a combination of pending transactions that spans 12 cultivation facilities (including Los Sueños Farms LLC, one of North America's largest sustainable cannabis farms); seven proprietary extraction facilities (including Purplebee's); seven manufacturers of infused products (including Medically Correct, one of Colorado's largest edible manufacturers; licensed producer of incredibles in Colorado, and creators of new brands Quiq and Nove, set to launch this fall); 33 strategically located retail dispensaries (including five Starbuds-branded dispensaries in Colorado); and a state-of-the-art manufacturing / research and development lab (MedPharm's Colorado facility has the first and only active cannabis research license in the state).
These acquisitions are made possible by the passage of House Bill 19-1090, which was signed into law by Colorado Gov. Jared Polis on May 29, 2019, thus opening up Colorado's cannabis industry to outside investors and enabling increased investment by venture capitalists and private equity firms. Medicine Man Technologies Chief Executive Officer Andy Williams was a major driving force behind the Colorado cannabis industry's push for public company ownership legislation, and he also sat on the rulemaking committee after the legislation was passed.
This new legislation allows public companies to wholly acquire licensed businesses in Colorado on or after Nov. 1, 2019, though these acquisitions would likely become final towards the end of the first or in the second quarter of 2020, pending due diligence, approval from local and state governments, and any other additional customary closing conditions.
"The natural progression of the modern cannabis industry is consolidation, and our vision for the future of Medicine Man Technologies has always been to bring together a group of experienced cannabis industry pioneers and the leading brands they've created—and we're proud to finally tell the world about this years-in-the-making strategy coming to fruition," said Andy Williams, Co-Founder and Chief Executive Officer of Medicine Man Technologies. "Not only are we banding together with other pioneers of the regulated cannabis market, but we're bringing together a dozen individually profitable companies into a single publicly traded outfit, and we believe we are strategically positioned to increase efficiencies and profit margin over time."
Medicine Man Technologies has entered into binding term sheets to acquire cultivation facility Los Sueños Farms LLC; diversified dispensary groups including Medicine Man, Colorado Harvest Company, Strawberry Fields, Roots Rx, Mesa Organics, and diverse dispensary locations owned by various ownership groups some run under the name Starbuds; infused products companies Medically Correct and Canyon LLC; concentrates manufacturers Dabble Extracts and Purplebee's; R&D, intellectual property and holding company / phytopharmaceutical-grade dosage form manufacturer (home to product brands become, BATCH and Aliviar) MedPharm Holdings; and Colombia-based Green Equity, which holds international import and export licenses and IP for cultivation, manufacturing, extraction and R&D—and a 271-acre farm located outside Bogotá.
These veteran executive teams have a combined 150-plus years of experience in regulated cannabis markets, including Medically Correct Founders Rick Scarpello and Bob Eschino, Los Sueños Farms Founder Bob DeGabrielle (who joined the Company's Board of Directors), Medicine Man Chief Executive Officer Sally Vander Veer, Co-Founder Pete Williams and Founding Member Pete Vasquez, Colorado Harvest Company Co-Founders Tim Cullen and Ralph Morgan, Canyon LLC Founder and Chief Executive Officer Morgan Iwersen, Starbuds Founder and Chief Executive Officer Brian Ruden and Managing Partner TJ Joudeh, Strawberry Fields Co-Founders Mike and Rich Kwesell, MedPharm Holdings Chief Executive Officer Albert Gutierrez, Mesa Organics Owners Jim and Pam Parco, Dabble Extracts Founder Josh Hindi, Roots Rx executives Robert Holmes and Steven Miller and others.
"Colorado operators are the most experienced and best-positioned operators in the world, and we've created some of the most tried-and-true brands in one of the most tightly regulated markets in the country," said Williams of Colorado's cannabis market, which is one of the largest cannabis markets in the U.S. "We've been watching the consolidation happening all around us, but while so many other multi-state operators have the money, they lack the experience with and passion for the plant. I like to say this collective talent pool has solved cannabis operating challenges that other companies don't yet know they are going to have. And soon we will have economies of scale on our side."
Most of these businesses report EBITDAs averaging around 20%, but Williams and his new colleagues believe they can increase those EBITDAs to approximately 30% via collaborative growth and the forthcoming economies of scale.
"Together we are creating Colorado's premier cannabis company," said Brian Ruden, Chief Executive Officer of Starbuds. "My colleague TJ Joudeh and I are proud to join forces with this team of Colorado cannabis pioneers, and we are confident that this network of industry-leading businesses across cultivation, extraction, production, retail and R&D business segments will become a formidable force in North American cannabis."
The Company has received a recent capital commitment up to $21 million from strategic partner Dye Capital, whose Managing Partner Justin Dye has 25 years of experience in private equity, general management, operations, strategy, corporate finance and M&A and was recently appointed Chairman of the Board of Medicine Man Technologies. Dye Capital Partner Leo Riera, who has more than 30 years of experience in investment banking and fund management and was the Country Head for Bankers Trust in Venezuela for over a decade, was also appointed to the Company's Board of Directors.
"This team has been strategically assembled for maximum impact—from my colleagues and myself in tactical plant-touching operations to our colleagues who bring vast experience in M&A and integration," said Medically Correct Founder Bob Eschino. "We are confident in this group's ability to fully take advantage of this first-of-its-kind opportunity."
The Company is prepared for the important work ahead, thanks to its experienced executives and consultants who bring essential skillsets in public markets to the table.
Chief Operating Officer Joe Puglise is a seasoned executive in operational management, including past work as President of New York properties for iHeartMedia, where he oversaw approximately 300 employees and almost $200 million in annual revenue and $100 million in annual EBITDA. Since Joe joined the Company in 2018, Medicine Man Technologies has gained over +165%, while the New Cannabis Ventures' Global Cannabis Stock Index tracker has retreated -10%, as of close of market Sept. 13, 2019. Senior Vice President of Finance Nancy Bush Huber brings over 25 years of executive management roles, including Chief Financial Officer and Vice President of Finance, for both public and private companies. Huber will be instrumental in establishing and managing the Company's financial reporting and capital allocation processes.
General Counsel, Hon. Dan Pabon, brings expertise in emerging regulatory systems and system design, and he also has established strategic federal, state and local relationships over his 20 years of involvement in public decision-making. Chief Administrative Officer Lee Dayton Jr. brings over 25 years of investment banking and corporate development experience. Chief Strategy Officer Todd Williams brings more than 25 years of asset valuation and M&A experience. Former United Airlines Chief Information Officer Nirup Krishnamurthy, a technology and operations executive with over 20 years of experience across industries, will lead the Company's technology integration. And at only 33, Chief Cultivation Officer Josh Haupt is already known as the "Steve Jobs of cannabis," having literally written the book, Three A Light, on cultivation excellence.
"This well-rounded team has been assembled to include experts from each side of the regulated cannabis and public markets paradigms, and MedPharm Holdings is honored to be joining forces with such thoughtful professionals—many of whom we've admired for years," said Dr. Tyrell Towle, MedPharm's Director of Chemistry and Extraction. "Medicine Man Technologies will be able to cover the cannabis life cycle from its foundations in agriculture to its many end uses with consumers, and the scientist in me is confident that this team has what it takes to create a world-class cannabis company that will continue to lead by example."
About Medicine Man Technologies
Denver, Colorado-based Medicine Man Technologies (OTCQX: MDCL) is a rapidly growing provider of cannabis consulting services, nutrients and supplies. The Company's client portfolio includes active and past clients in 20 states and seven countries throughout the cannabis industry. The Company has entered into agreements to become one of the largest vertically integrated seed-to-sale operators in the global cannabis industry. Current agreements will enable Medicine Man Technologies to offer cultivation, extraction, distribution and retail pharma-grade products internationally. The Company's intellectual property includes the "Three A Light" methodology for cannabis cultivation and pending acquisition candidate MedPharm's GMP-certified facility, which has the first cannabis research license to conduct clinical trials in the United States. Management includes decades of cannabis experience, a unique combination of first movers in industrial cannabis and proven Fortune 500 corporate executives.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) regulatory limitations on our products and services; (ii) our ability to complete and integrate acquisitions; (iii) general industry and economic conditions; and (iv) our ability to access adequate financing on terms and conditions that are acceptable to us, as well as other risks identified in our filings with the SEC. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise. We note that as to all referenced potential acquisitions: (i) we have not performed business, financial, accounting or legal due diligence, (ii) each contemplates entering into a definitive agreement and no such definitive agreement has been executed,(iii) financial information and projections relating to these potential acquisitions is based solely on information provided by the target companies, without review by us or independent verification, and historical financial information of the potential acquisitions targets is unaudited , (iv) each of these potential acquisitions and any projected financial information is subject to substantial risks and uncertainties,(v) completing these acquisitions and executing on our strategy will require MMT to secure additional financing and (vi) completing each of these acquisitions is subject to obtaining regulatory approvals. There can be no assurance that the proposed acquisitions will in fact be consummated on the terms and in the manner previously disclosed or at all. Forward looking statements are dynamic and subject to change. Our forward-looking statements speak only as of the date they are given and do not necessarily reflect our outlook at any other point in time. We do not undertake to update or revise these forward-looking statements. Inevitably some assumptions underlying projections will not materialize and unexpected events and circumstances may affect ultimate financial results. Projections are inherently subject to substantial and numerous uncertainties and to a wide variety of significant business, economic, regulatory, and competitive risks. Actual results achieved may vary materially from the projections or other forward-looking statements. There are substantial risks and uncertainties relating to integrating an acquisition and we contemplate completing and integrating a substantial number of acquisitions which enhances the risks and uncertainties.
Investor Relations Contact:
ir@medicinemantechnologies.com
1-866-348-1997
Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/medicine-man-technologies-highlights-landmark-consolidation-strategy-to-create-one-of-north-americas-largest-vertically-integrated-cannabis-operators--projected-annual-revenues-from-the-previously-disclosed-proposed-acquisitions-300918527.html
SOURCE Medicine Man Technologies, Inc.
We have another deal this morning
Medicine Man Technologies to Increase Its Manufacturing Efficiencies and Branded Product Offerings with Binding Term Sheet for Canyon LLC
Press Release | 09/12/2019
Medicine Man Technologies to Increase Its Manufacturing Efficiencies and Branded Product Offerings with Binding Term Sheet for Canyon LLC
- Another industry pioneer that is considered one of Colorado's leading manufacturers of all-natural, highly effective premium-infused edibles
- Utilizes proprietary CO² extraction process free of any non-medicinal plant constituents to isolate cannabis essential oil from plant materials
- One of the leaders in the micro-dosing cannabis movement, with revenue from its gummies growing over 250% YOY
- All its edible products are GMO-free and made in-house with all-natural or organic ingredients sourced locally whenever possible
PR Newswire
DENVER, Sept. 12, 2019
DENVER, Sept. 12, 2019 /PRNewswire/ -- Medicine Man Technologies, Inc. (OTCQX: MDCL) ("Medicine Man Technologies" or the "Company"), announced today that it has entered into a binding term sheet to acquire Canyon LLC ("Canyon"), a leading Colorado manufacturer of all-natural, discreet, and highly effective premium-infused edibles.
Under the terms of the transaction, Medicine Man Technologies will purchase Canyon LLC for $5.13 million, payable in cash and common stock of the Company that will be determined and set forth in the long form agreement among the parties. The cash consideration, however, will not be greater than $2.565 million and the shares of common stock will be valued at $3.07 per share. Based upon the year-to-date results, Canyon is expected to generate gross revenues of $3.3 million in 2019. The purchase price may be subject to adjustment, which will be detailed in the long form agreement entered into among the parties.
"Our latest series of announcements have been predicated on building out our footprint of retail dispensaries," said Andy Williams, Co-Founder and Chief Executive Officer of Medicine Man Technologies. "Canyon has been on our radar for several years given its strong following and high quality manufacturing and extraction methods. Its proprietary process using CO2 to extract cannabis oil from plant materials yields flavorful products. From hard candies, capsules, and micro-dosed gummies to its cannabis-infused beverages, the unique products derived from its cannabis oil have gained a deserving reputation and garnered a tremendous customer base. We believe this acquisition is important in furthering the build-out of our infrastructure and diversifying our branded product offerings."
"Like Andy and the rest of his growing family of industry pioneers, we have been around since before the state went recreational," said Morgan Iwersen, Founder, Co-Owner, and Chief Executive Officer of Canyon LLC. "We have conducted business with Andy over the years and have also come to recognize and admire him for being an influential driving force for our industry. With a lot of bigger corporate competitors looking to enter the state now, we felt it was time to join the Medicine Man Technologies family to help build a stronger unified company that can remain competitive with these larger corporations but still maintain the authenticity of our Colorado roots."
"The time is right for Colorado companies to join forces and create a more expandable and national brand that can grow profitably despite external competition from corporate cannabis," added Andrew Iwersen, Co-Owner and Managing Partner of Canyon LLC.
Management cautions that there can be no assurance that the targeted acquisition will achieve the stated gross revenue projection.
More information regarding the binding term sheet, including the closing conditions, are set forth in the Company's current report on Form 8-K.
For more information about Medicine Man Technologies, please visit https://www.medicinemantechnologies.com.
About Canyon LLC
Founded in 2009, Canyon LLC is one of Colorado's leading manufacturers of all-natural, discreet, and highly effective premium-infused edibles. All of its products are gluten-free, GMO-free, and made in-house using a proprietary extraction process that uses high-quality all-natural ingredients and is completely free of any non-medicinal plant constituents. Each batch of essential cannabis oil produced is tested both on and off-site to ensure that every dose its customers consume is pure and safe and delivers the same level of relief every time. Its hard candies, suckers, capsules, and cannabis-infused nitro brew coffee are known for their delicious flavors, long-lasting effects, and minimal cannabis flavor.
About Medicine Man Technologies
Denver, Colorado-based Medicine Man Technologies (OTCQX: MDCL) is a rapidly growing provider of cannabis consulting services, nutrients, and supplies. The Company's client portfolio includes active and past clients in 20 states and seven countries throughout the cannabis industry. The Company has entered into agreements to become one of the largest vertically integrated seed-to-sale operators in the global cannabis industry. Current agreements will enable Medicine Man Technologies to offer cultivation, extraction, distribution and retail pharma-grade products internationally. The Company's intellectual property includes the "Three A Light" methodology for cannabis cultivation and pending acquisition candidate MedPharm's GMP-certified facility, which has the first cannabis research license to conduct clinical trials in the United States. Management includes decades of cannabis experience, a unique combination of first movers in industrial cannabis and proven Fortune 500 corporate executives.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations, and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Such risks and uncertainties include, without limitation, risks, and uncertainties associated with (i) regulatory limitations on our products and services; (ii) our ability to complete and integrate acquisitions; (iii) general industry and economic conditions; and (iv) our ability to access adequate financing on terms and conditions that are acceptable to us, as well as other risks identified in our filings with the SEC. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events, or otherwise.
Investor Relations Contact:
ir@medicinemantechnologies.com
1-866-348-1997
Unless something earth shattering bad news comes out, we keep creeping higher with a new higher base. The $.50 bid the past two days not even getting hit by the $.51 cent sellers is a good sign. Wouldn't be surprise to see FIFG close at a new 52 week high above $.60 going into the weekend.
Good luck to all.
Just some personal thoughts/observations/opinions of what is going on right now here in the stock price of MDCL.
In my 40+ years of trading/investing, I have never seen a stock scream "buy me" and have the potential of MDCL. They are profitable and are excellently managed and making incredible acquisitions. Andy Williams and the late Brett Roper obviously had a amazing plan to grow the company once the cannabis laws were going to change. Bringing on an investor like Dye Capital was the final straw to execute the plan.
Concerning the stock price, I would love to see the stock price in the $5-$6 range currently but a few of you are loving the opportunity to grab some additional shares cheaper. I don't think we will be at this price level much longer but this is the 2 reasons why I feel it hasn't moved up.
The first is that the MDCL is taking over companies that aren't publicly traded so the financials are really not known to the Wall Street community and the financial analysts can't get their hands around it and figure how these deals will work out. I trust Andy Williams that he is making smart and profitable deals and they will add to the bottom line. Only the management of these companies and MDCL know the numbers and how they will combine to the bottom line. I also believe Dye Capital made the investment because they felt these deals were winners.
The second is that MDCL is purchasing companies at a incredible rate so when the analysts feel they get a handle on the situation, they get thrown another loop and it screws up their numbers again. I believe the scenario of growing too fast too soon can give the perception that MDCL is biting off a little too much instead of waiting to see how some of the acquisitions pan out.
We are just around the corner in the next few months all these deals will be finalized and acquisition write-offs will be overcome by the incredible revenues and the blast off will begin. Good luck to all.
First Foods Group Launches New Brand and Signs an LOI with CBD Unlimited
Press Release | 08/14/2019
NEW YORK, NY, Aug. 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – First Foods Group, Inc. (OTCQB: FIFG) has announced today that it has launched its first hemp-based premium chocolate product line available now to consumers under the brand name, “Southeast Edibles.” First Foods has been eagerly anticipating the legalization of hemp-based products in the state of Florida, where it has been refining its chocolate edibles recipes in its state-of-the-art chocolate production facility since March of this year. First Foods has been thoroughly and thoughtfully working behind the scenes to position itself as a market leader who is ready and able to capture the nationwide chocolate edibles market.
First Foods strategic focus and tactical market positioning came to fruition on July 1, 2019 when Florida’s governor legalized hemp-based products. First Foods immediately responded to this historical event on August 9, 2019 by simultaneously launching its Southeast Edibles brand and signing a letter of intent with CBD Unlimited, Inc. (OTCQB: EDXC), which is a leading researcher, manufacturer and distributor of a wide range of CBD products that have been scientifically designed and tested to perfect the delivery of accurate CBD dosage.
“First Food Group is a creative and emerging brand that will help drive our consumable product category as the growth of the CBD marketplace is accelerating rapidly,” CBD Unlimited CEO & Chairman Todd Davis stated. “We look forward to this opportunity to collaborate with such a successful management team as we strive to provide consumers with a variety of superb products.”
“We have purposely followed a methodical approach to introducing our product lines to market. Identifying and vetting only the best teaming partners are key to our long-term success. CBD Unlimited's scientific approach, loyal customer base and expanding market access gives us confidence that they are an ideal partner to help bring our products to discerning customers who demand quality chocolate edibles that have an exceptional taste and deliver a consistent and reliable dose of hemp-based ingredients,” according to Harold Kestenbaum, CEO and Chairman of FIFG.
Mr. Kestenbaum also states, "Over the past year, First Foods Group has structured and put to motion a team of first-rate professionals to develop and launch its luxury brands of gourmet chocolates with CBD infusions, which are uniquely positioned for widespread distribution to “Big Box” chains. The team has worked cohesively to cultivate distinctive product lines, brand identities, target audiences, web presence and ultimate market acceptance.”
Company management has been and remains singularly focused on creating their own chocolate from carefully selected raw materials, including cacao beans that come directly from well-established farms located throughout South America that enjoy long-standing, personal relationships with FIFG’s third-generation chocolatier. The Company’s Holy Cacao chocolate is infused with only the best hemp extracts.
Company executives selected Southeast Edibles as FIFG’s initial brand because it offers a broad spectrum of premium chocolate in dark, dairy free milk, and white varieties that are all available with different concentrations of CBD. The Company has featured Southeast Edibles in a brand-new website and e-commerce shop, which is positioned today to fulfill purchase orders from inaugural buyers from targeted states.
Readers should keep in mind that Southeast Edibles is just the beginning for FIFG. Company management is diligently working on targeting every segment of the market and plans to unveil their ultra-premium brand, "Purely Irresistible" in the near term. Stay tuned.
About First Food Group, Inc.
First Foods Group, Inc. provides management services and funding options for emerging food brands and menu concepts. First Foods Group, Inc. is also growing its own new concepts, both through proprietary development and through mergers, acquisitions, and licensing arrangements. First Foods Group has assembled a team of distinguished food service professionals with experience and success at the highest levels of the industry.
About CBD Unlimited, Inc.
CBD Unlimited. Inc. develops and distributes all-natural products from the cannabis sativa L plant (hemp) with less than 0.01% THC. Its products range from oils, capsules, topicals, and pet products, all with the shared purpose of high therapeutic value. The science behind these products involves nearly a decade of research and experiments in order to perfect the accuracy in dosage and delivery of absorption per serving.
In order to provide conformity with federal and state mandates, the company has incorporated its “Gorilla-Tek” platform into their business practices. The Gorilla-Tek platform is the first standardized hardware agnostic and software solution that tracks high-risk, high-shrink, regulated and restricted products maintained under federal/state/local regulations. The platform provides asset protection, inventory management, compliance and an “end of sale” technology integration. Gorilla-Tek is tremendously efficient, as it provides up-to-the-minute accounting and product details and GEO-location for consumer apps. Gorilla-Tek increases productivity, while reducing costs for retailers and costs in time for customers.
Safe Harbor Notice
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The company undertakes no obligation to update any forward-looking statements.
Contact:
For further investor and media information, contact:
COMPANY: First Foods Group, Inc.
Contact: 201-471-0988; info@firstfoodsgroup.com
CBD Unlimited Signs Letter of Intent with First Food Group, Inc.
Press Release | 08/14/2019
CAVE CREEK, AZ, Aug. 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – CBD Unlimited, Inc., formerly known as Endexx Corporation (EDXC), a provider of innovative phytonutrient-based food and nutritional products, announced today it has entered into a letter of intent (“LOI”) with leading chocolate manufacturer, First Food Group, Inc. (FIFG) to collaborate on premium CBD-infused chocolates.
In collaboration, CBD Unlimited and First Food Group will formulate and distribute premium CBD-crafted chocolates and seasonal treats. First Food Group, Inc. is a highly rated chocolate manufacturer that identifies and creates emerging unique food concepts. With the growing awareness and demand of hemp-derived CBD, the Company continues to position itself to be a market leader in premium ingestible CBD products. CBD Unlimited continues to achieve significant sales’ milestones throughout 2019, expecting tremendous growth in fiscal 2020. The Company seeks to add this new product line to its premium suite of products. As high demand for premium products increase, CBD Unlimited believes this partnership will enhance its product selection into key distribution channels.
“First Food Group is a creative and emerging brand that will help drive our consumable product category as the growth of the CBD marketplace is accelerating rapidly,” CEO & Chairman Todd Davis stated. “We look forward to this opportunity to collaborate with such a successful management team as we strive to provide consumers with a variety of superb products.”
Harold L. Kestenbaum, CEO & Chairman of First Foods Group, stated, "We have purposely followed a thorough and thoughtful approach introducing our product lines to market, especially given the fact that hemp-based ingredients only became legal in Florida on July 1, 2019. Identifying and vetting the right partners are key success factors in our marketing strategy. CBD Unlimited's scientific approach, loyal customer base and expanding market access gives us confidence that they are an ideal partner to help bring our products to the public.”
About First Food Group, Inc.
First Foods Group, Inc. provides management services and funding options for emerging food brands and menu concepts. First Foods Group, Inc. is also growing its own new concepts, both through proprietary development and through mergers, acquisitions, and licensing arrangements. First Foods Group has assembled a team of distinguished food service professionals with experience and success at the highest levels of the industry.
About CBD Unlimited, Inc.
CBD Unlimited. Inc. develops and distributes all-natural products from the cannabis sativa L plant (hemp) with less than 0.01% THC. Its products range from oils, capsules, topicals, and pet products, all with the shared purpose of high therapeutic value. The science behind these products involves nearly a decade of research and experiments in order to perfect the accuracy in dosage and delivery of absorption per serving.
In order to provide conformity with federal and state mandates, the company has incorporated its “Gorilla-Tek” platform into their business practices. The Gorilla-Tek platform is the first standardized hardware agnostic and software solution that tracks high-risk, high-shrink, regulated and restricted products maintained under federal/state/local regulations. The platform provides asset protection, inventory management, compliance and an “end of sale” technology integration. Gorilla-Tek is tremendously efficient, as it provides up-to-the-minute accounting and product details and GEO-location for consumer apps. Gorilla-Tek increases productivity, while reducing costs for retailers and costs in time for customers.
Website: www.cbdunlimited.com
Safe Harbor Notice
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The company undertakes no obligation to update any forward-looking statements.
For further investor and media information, contact:
CBD Unlimited, Inc.
Todd Davis
Chairman & CEO
Todd@cbdunlimited.com
480-595-6900
First Food Group
info@firstfoodsgrp.com
201-471-0988
The entire OTCBB website is having what I presumed a technical problem so all the stocks are not showing the best bid or offer in the quote. Obviously the Level 2 quotation system is working so you can still see the best bids and offers.
And when the news does come, watch out. I just admire management for the profitability with the merchant bank end of the business to be profitable and not to be doing private share placements to fund operations. This company definitely has all the signs of a winner. I am excited about the future and think a takeoff in price is any day now.
This is what happens when you get day traders and computer program trading. Everyone who is a long term holder and sees the potential wants something to happen everyday (I know I do) but know that is unrealistic. The day traders (or short term traders) start to get spooked and unloaded to lock in small profits or keep their losses to a minimum. The computer algorithms read the chart and escalate the downward pressure along with market makers who look to take out the weak hearted.
This stock just based on the deals on the table should be trading at $10.00 a share with 4 or 5 times the revenue stream in the future. MDCL is one of only a very few cannabis companies that is profitable. Realistically it should be a $20-25 dollar stock range (based on past news) and if the federal government ever makes cannabis/marijuana legal, then this is a $50.00 stock.
I have been a long term holder almost since the company has gone public on the stock market and has flipped a few shares from time to time, but do not want to miss out on the big run. Any shattering news and this stock doubles in one day and then takes off from there.
Hard to be patient and I feel your pain but hang in there. This company is a light of shining armor in a very crowded field but it will be one of the survivors and a beacon of the industry. Good luck to all.
There was a seller of 25,000 shares at $.37 two days ago which didn't show up yesterday. Probably just waiting to see a bid at that price to sell it all. Excellent to see additional buyers stepping up slowly.
There was your taker at $.32 but I think someone got a little nervous. Anyone could jump right back in at the $.37-.40 level since there is some offers there, but after that it could be clear sailing. Good luck to all.
Yes, it was an excellent presentation. Glad to see that Paul Dickman sold some shares for a personal nature and will still be active in the company and not leaving.
There was that interesting question about other big market cannabis companies making an attempt to either merge or takeover MDCL which can only help the share price down the road if an overture from another company was to take place. I believe it would be in the best interest to stay solo, but if the price is right it sure wouldn't hurt or be easy to turn down.
Just incredibly impressed by Andy Williams and what he (and Brett Roper) has accomplished. How sad that Brett Roper isn't here to enjoy the accomplishments but I am sure he cheering and watching over this from above and bringing good things our way.
This is the most exciting small cap stock I have ever owned and I believe we will all be incredibly rewarded in the near future. Best wishes to all.
Of course we don't know for sure why he did sell, but if I remember right then I am pretty sure he has options to buy the around the $1.35 range which means he takes the money and can buy 3 times amount of the stock and really fill his pockets with cash down the line. Just a guess in my opinion.
It is always frustrating to see insiders sell, but they do sometimes have lock up periods in which they can't sell shares so they need to do in the time periods allowed.
I think with Andy Williams getting an bonus of 1 million shares at the $8.00 level pretty much assures us that he wouldn't have agreed to it unless he was comfortable reaching that level.
Best wishes to all and hang in there!
CEO Harold Kestenbaum Reports on Current Operations/New Developments
NEW YORK, NY, June 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- First Foods Group, Inc.(FIFG) has released the following update from its CEO and Chairman, Harold Kestenbaum.
"Over the past year, First Foods Group(FIFG) has structured and put to work a team of first-rate professionals to develop and launch our luxury and big-box positioned, gourmet chocolate that is compatible with both CBD and THC offerings. The team has worked cohesively to cultivate brand identities, target audiences, create web presence and more under the direction of its Board of Directors. We are confident our structure and plan of operations will continue to enhance our shareholders' long-term interests. I’m now happy to report tremendous strides in our brand development and our readiness for Florida legislative actions in 2019 that can positively impact our product manufacturing, packaging, distribution and sale.
"Since the new year, we’ve secured and begun commercial production in our brand-new warehouse, located in Broward County, Florida which we were fortunate to find fully furnished with state of the art, food-grade manufacturing facilities and equipment. Our narrative of offerings have been fine-tuned by the palette of our third-generation chocolatier who has been dedicated day and night to formulating and blending our quality ingredients into superior offerings. We have decided to offer our luxury THC brand under the name Mystére and market our luxury CBD brand as Purely Irresistible. We are thrilled to be able to launch these brands and continue to develop cutting-edge products for our subsidiary lines to reach a broad and diverse array of consumers.
“And today, with great pride, I can announce to you that as of last month, we received our first completed purchase order for our first three products, including volume of over 3,000 pounds of chocolate for over $30,000. This will place us in position to have additional specialty chocolate products on shelves in the third quarter of this year.
"We can clearly see the culmination of efforts manifesting in the growth of our product lines and thriving brand. We are excited for what’s to come."
Cautionary Language Concerning Forward-Looking Statements
This press release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. In addition to statements which explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms "believes", "belief", "expects", "intends", "anticipates", "will", or "plans" to be uncertain and forward looking. The forward-looking statements contained herein are subject generally to other risks and uncertainties that are described occasionally in company's reports and registration statements filed with Securities and Exchange Commission.
COMPANY CONTACT: 201-471-0988; info@firstfoodsgrp.com
Image: First-Foods-Logo.png
Source: First Foods Group(FIFG)
2019 GlobeNewswire, Inc.
Medicine Man Technologies, Inc. Announces Appointments of New Chief Strategy Officer and VP of Integration - Todd Williams brings 24+ years of consulting, asset valuation and M&A strategy experience to his role as Chief Strategy Officer - Collin Lodge brings 6+ years of corporate development, integration and change management, and acquisition strategy to his role as VP of Integration DENVER, June 18, 2019 /PRNewswire/ -- Medicine Man Technologies, Inc. (OTCQX: MDCL) ("Medicine Man Technologies" or "Company"), a rapidly growing, vertically integrated cannabis operator, today announced the appointments of Todd Williams as Chief Strategy Officer and Collin Lodge as Vice President of Integration.
"On behalf of Medicine Man Technologies, I am pleased to welcome Todd and Collin to the team," said Mr. Andy Williams, Co-Founder and Chief Executive Officer of Medicine Man Technologies. "As we continue to grow and increase our capabilities as a fully vertically integrated cannabis operator, these new executive team members contribute impressive track records in advancing the development of acquisitions for highly successful companies and executing strategic decisions that the Company will benefit from. They join Medicine Man Technologies at an exciting time, and I am confident they will play integral roles as the Company further develops its operations on a global scale and drive profitability to enhance value for shareholders." Todd Williams joins Medicine Man Technologies as Chief Strategy Officer, with more than 24 years of consulting, strategy, asset valuation and M&A experience. In his most recent role in Corporate Development at Albertsons Companies, he managed the acquisition of over 1,600 operating grocery stores with more than $40 billion in sales and $10 billion in transaction value and was also responsible for divesting 168 stores with over $3 billion in sales. Previously, Mr. Williams has held asset valuation and management positions in real estate and commodity trading, as well as management consulting positions with Arthur Andersen LLP and Electronic Data Systems. He received a B.A. from DePauw University and graduated with academic honors. Collin Lodge comes on board as Vice President of Integration after six years serving as the Director of Corporate Development and Strategy at Albertsons Companies. He participated in transformational retail projects, including the acquisition of Safeway's 2,230 stores nationwide and the corresponding required Federal Trade Commission ("FTC") divestitures, one of the largest FTC decisions in U.S. history at the time. Mr. Lodge has also supported growth into new business segments following the acquisitions of MedCart Specialty Pharmacy and Plated, both in 2017. He has a history of establishing mutually beneficial strategic structures and brings significant integration and change management experience to the Company. He is an MBA graduate of Boise State University and received his B.S. in finance from the University of Idaho. For more information about Medicine Man Technologies, please visit https://www.medicinemantechnologies.com/.
Here is the price of the acquisitions
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 24, 2019
Medicine Man Technologies, Inc.
(Exact name of registrant as specified in its charter)
Nevada
001-36868
46-5289499
(State or other jurisdiction of
incorporation or organization)
(Commission
File Number)
IRS Employer
Identification No.)
4880 Havana Street, Suite 201
Denver, Colorado
80239
(Address of Principal Executive Offices)
(Zip Code)
(303) 371-0387
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):
?
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
?
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
?
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
?
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: None
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ?
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ?
Item 1.01 Entry into a Material Definitive Agreement.
On May 24, 2019 (the “Farm Boy Execution Date”), Medicine Man Technologies (the “Company”), a Nevada corporation, entered into a binding term sheet (the “Farm Boy Term Sheet”) with Farm Boy, LLC (“Farm Boy”) and Baseball 18, LLC (“Baseball”), each a Colorado limited liability company, setting forth the terms of the acquisition by the Company of 100% of the capital stock and assets of Farm Boy and Baseball respectively (the “Farm Boy Acquisition”).
The terms of the Farm Boy Term Sheet are summarized as follows:
As consideration, the Company shall pay a total purchase price of $5,937,500 (the Farm Boy Purchase Price”), subject to adjustment, consisting of $1,187,500 cash and 1,578,073 shares of its common stock, par value $0.001 per share. The 1,578,073 shares was determined by averaging the closing price of Company’s common stock for the five (5) days prior to the Farm Boy Execution Date, which equated to $3.01 per share.
The Farm Boy Purchase Price is predicated on projected 2019 gross revenues of Farm Boy and Baseball. The Farm Boy Purchase Price will be adjusted to reflect the actual 2019 gross revenues on a date and method mutually agreed upon by the Company, Farm Boy and Baseball and memorialized in the Farm Boy Long-Form Agreement (as defined below).
Additionally, Mr. Bob DeGabrielle shall agree to join the Company’s Board of Directors for a period of one (1) year, renewable my mutual agreement between the Company and Mr. DeGabrielle.
The obligations of the Company, Farm Boy and Baseball under the Farm Boy Term Sheet are conditioned upon the satisfaction or mutual waiver of the following conditions (the “Farm Boy Conditions”):
i.
regulatory approval of the Marijuana Enforcement Division;
ii.
approval from applicable state and local licensing authorities;
iii.
receipt of all required third party consents to allow for the Company’s assumption of Farm Boy and Baseball contracts;
iv.
all of Farm Boy’ and Baseball’s capital stock and assets are transferred to the Company free and clear of all liens, claims and security interests;
v.
the Company’s payment of $1,187,500 cash and 25% of the share component of the Farm Boy Purchase Price to Farm Boy and Baseball; and
vi.
all additional conditions as set forth in the Farm Boy Term Sheet.
The Farm Boy Term sheet contemplates the parties entering into a long-form agreement and other ancillary documents to memorialize the Farm Boy Acquisition (the “Farm Boy Long-Form Agreement”). In the event the Farm Boy Long-Form Agreement is not agreed to within one year of the Farm Boy Execution Date and all of the Farm Boy Conditions are either satisfied or waived, the Farm Boy Acquisition shall be consummated and governed by the terms of the Farm Boy Term Sheet.
On May 24, 2019 (the “Los Suenos Execution Date”), the Company entered into a binding term sheet (the “Los Suenos Term Sheet”) with Los Suenos, LLC (“Los Suenos”) and Emerald Fields Grow, LLC (“Emerald”), each a Colorado limited liability company, setting forth the terms of the acquisition by the Company of 100% of the capital stock and assets of Los Suenos and Emerald respectively (the “Los Suenos Acquisition”).
The terms of the Los Suenos Term Sheet are summarized as follows:
As consideration, the Company shall pay a total purchase price of $5,937,500 (the “Los Suenos Purchase Price”), subject to adjustment, consisting of $1,187,500 cash and 1,578,073 shares of its common stock, par value $0.001 per share. The 1,578,073 shares was determined by averaging the closing price of Company’s common stock for the five (5) days prior to the Los Suenos Execution Date, which equated to $3.01 per share.
The Los Suenos Purchase Price is predicated on projected 2019 gross revenues of Los Suenos and Emerald. The Los Suenos Purchase Price will be adjusted to reflect the actual 2019 gross revenues on a date and method mutually agreed upon by the Company, Los Suenos and Emerald and memorialized in the Los Suenos Long-Form Agreement (as defined below).
2
The obligations of the Company, Los Suenos and Emerald under the Los Suenos Term Sheet are conditioned upon the satisfaction or mutual waiver of the following conditions (the “Los Suenos Conditions”):
i.
regulatory approval of the Marijuana Enforcement Division;
ii.
approval from applicable state and local licensing authorities;
iii.
receipt of all required third party consents to allow for the Company’s assumption of Los Suenos and Emerald contracts;
iv.
all of Los Suenos’ and Emerald’s capital stock and assets are transferred to the Company free and clear of all liens, claims and security interests;
v.
the Company’s payment of $1,187,500 cash and 25% of the share component of the Los Suenos Purchase Price to Los Suenos and Emerald; and
vi.
all additional conditions as set forth in the Los Suenos Term Sheet.
The Los Suenos Term sheet contemplates the parties entering into a long-form agreement and other ancillary documents to memorialize the Los Suenos Acquisition (the “Los Suenos Long-Form Agreement”). In the event the Los Suenos Long-Form Agreement is not agreed to within one year of the Los Suenos Execution Date and all of the Los Suenos Conditions are either satisfied or waived, the Los Suenos Acquisition shall be consummated governed by the terms of Los Suenos Term Sheet.
On May 31, 2019 (the “MesaPur Execution Date”), the Company entered into a binding term sheet (the “MesaPur Term Sheet”) with Mesa Organics Ltd., Mesa Organics II Ltd. and Mesa Organics III Ltd., each a Colorado limited liability company and collectively “MesaPur,” setting forth the terms of the acquisition by the Company of 100% of the capital stock and assets of MesaPur (the “MesaPur Acquisition”).
The terms of the MesaPur Term Sheet are summarized as follows:
As consideration, the Company shall pay a total purchase price of $12,012,758.20 (the “MesaPur Purchase Price”), subject to adjustment, consisting of $2,402,551.64 cash and 2,801,809 shares of its common stock, par value $0.001 per share. The 2,801,809 shares was determined by averaging the closing price of Company’s common stock for the ten (10) days prior to the MesaPur Execution Date, which equated to $3.43 per share.
The MesaPur Purchase Price is predicated on i) projected annual gross revenues of MesaPur, to be measured once all three MesaPur Colorado locations are open and operating, and ii) the assumption of debts associated with the normal course of MesaPur’s business. The MesaPur Purchase Price will be adjusted to reflect the actual gross revenue run rate on a date and using a method mutually agreed upon by the Company and MesaPur and memorialized in the MesaPur Long-Form Agreement (as defined below).
The obligations of the Company and MesaPur under the MesaPur Term Sheet are conditioned upon the satisfaction or mutual waiver of the following conditions (the “MesaPur Conditions”):
i.
regulatory approval of the Marijuana Enforcement Division;
ii.
approval from applicable state and local licensing authorities;
iii.
receipt of all required third party consents to allow for the Company’s assumption of MesaPur contracts;
iv.
all of MesaPur’s capital stock and assets are transferred to the Company free and clear of all liens, claims and security interests;
v.
the Company’s payment of the MesaPur Purchase Price to MesaPur;
vi.
the execution of certain property leases and employment agreements; and
vii.
all additional conditions as set forth in the MesaPur Term Sheet.
The MesaPur Term sheet contemplates the parties entering into a long-form agreement and other ancillary documents to memorialize the MesaPur Acquisition (the “MesaPur Long-Form Agreement”). At the closing of the MesaPur Long-Form Agreement, the Company shall enter into individual employment agreements with certain individuals as set forth in the MesaPur Term Sheet.
In the event the MesaPur Long-Form Agreement is not agreed to within one year of the MesaPur Execution Date and all of the MesaPur Conditions are either satisfied or waived, the MesaPur Acquisition shall be consummated and governed by the terms of MesaPur Term Sheet.
3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Medicine Man Technologies, Inc.
Date: June 5, 2019
By:
/s/ Andrew Williams
Name:
Andrew Williams
Title:
Chief Executive Officer
Wing,
Happy to see that initial order but I need to see additional orders and sales to really get pumped. But it is a good start and the potential is there. Also, glad to see the Cash Merchant business keeping revenue flowing into the company which gives FIFG less need to dilute shares into the market to raise cash to help fund Holy Cacao. Just glad to be invested at this level because the upside could be huge while not having that much risk at this low price. If we can get another order for Holy Cacao, that could really start to move this stock.
Good luck,
Hoop
1st quarter loss (-.02) vs (-.03)
Cash merchant revenues rising. If they can get the Holy Cacao brand producing and sales off the ground, this could rocket to $5.00 - $10.00 a share with the low float. Good luck to all and much patience.
https://www.sec.gov/Archives/edgar/data/1648903/000147793219002647/fifg_10q.htm
Medicine Man Technologies Inc. (MDCL) Names Co-Founder Andy Williams as Chief Executive Officer
Williams served as interim CEO for five months; continues to spearhead pending acquisitions of MedPharm Holdings LLC and Medicine Man Denver
PR Newswire
DENVER, April 23, 2019
DENVER, April 23, 2019 /PRNewswire/ -- Medicine Man Technologies Inc.(MDCL) ("Medicine Man Technologies" or " Company"), a rapidly growing, vertically integrated operator, announced that the Company has named Co-Founder Andy Williams as Chief Executive Officer after serving as interim CEO for the past five months.
Williams was named as the interim CEO in early December, after the untimely passing of Brett Roper, Medicine Man Technologies'(MDCL) previous CEO. As interim CEO, Williams has supervised the pending transactions of MedPharm Holdings LLC and Medicine Man Denver, the former of which is expected to close in June. The combined companies will have a revenue run rate between $40 and $50 million.
"As Co-Founder of Medicine Man, I am extremely proud of the brand we have built and where we are today," says Mr. Andy Williams. "These are exciting times as we move toward our ultimate goal of becoming a vertically integrated cannabis operator. I am honored to continue Brett's legacy by leading Medicine Man Technologies'(MDCL) future growth and our long-term success."
The MedPharm acquisition will come with the only cannabis research license to develop pharmaceutical-grade products using best-in-class extraction, analytical testing and formulation development to help better understand various diseases including Alzheimer's and dementia.
The pending acquisition of Medicine Man Denver includes four Colorado retail locations and a 40,000-square-foot cultivation operation that will add an estimated $25 million of annual revenue to Medicine Man Technologies(MDCL). The Medicine Man Denver acquisition is pending the passing of House Bill 19-1090 in the Colorado state legislature, which will allow publicly traded companies to own and operate cannabis licenses.
For more information about Medicine Man Technologies(MDCL), please visit https://www.medicinemantechnologies.com/.
About Medicine Man Technologies(MDCL)
Medicine Man Technologies (MDCL) is a fully integrated operator in the cannabis industry, offering consulting, cultivation supplies and equipment, retail pharma-grade products and turnkey solutions for cannabis producers, processors and retailers for nearly a decade. Medicine Man Technologies(MDCL) is leveraging its expertise and intellectual property to vertically integrate retail, cultivation, formulation and distribution operations. The Company's client portfolio includes active and past clients in 18 states and seven countries.
Forward-Looking Statements
This press release contains "forward-looking statements." Such statements may be preceded by the words "intends," " may," "will," "plans, " "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," " potential," or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control and cannot be predicted or quantified. Consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) our inability to manufacture our products and product candidates on a commercial scale on our own or in collaboration with third parties; (ii) difficulties in obtaining financing on commercially reasonable terms; (iii) changes in the size and nature of our competition; (iv) loss of one or more key executives or scientists; and (v) difficulties in securing regulatory approval to market our products and product candidates. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the Securities and Exchange Commission (SEC), including the Company's Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC's website at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.
Investor Relations Contact:
ir@medicinemantechnologies.com
1-866-348-1997
View original content to download multimedia:http://www.prnewswire.com/news-releases/medicine-man-technologies-inc- names-co-founder-andy-williams-as-chief-executive-officer-300836713.html
SOURCE Medicine Man Technologies Inc.(MDCL)
/Web site: http://www.medicinemantechnologies.com
(END) Dow Jones Newswires (212-416-2800)
04-23-191441ET
Copyright (c) 2019 Dow Jones & Company, Inc.
The market makers love the sell stops and took the rest of them out around $3.00 and below. Should find a base and support here before we make a turnaround. Disappointed we didn't hold the $3.20 level but we should have a lot of day traders in this stock with the recent volume activity. I am looking long term and not the quick flip because we could be caught off guard and miss the big run. I see at least $20.00 by the end of the year, probably a good deal higher.
Good luck to all.
And nice to see solid consolidation at record volume numbers, great times still to come
Love the pullback today to create a new higher bottom and get out the weak day traders. That is healthy for the stock.
This is a far fetched idea, but I wouldn't be surprised to see an announcement sometime in the not too distant future of a bigger name/size cannabis company taking a equity/position stake in MDCL due to them being one of the best in the business and also being profitable. Just a wild guess but seeing that a big majority of the buyers are coming through the Canadian market makers makes me believe that could be a possibility. A outlandish takeover price for MDCL would be a great coup from one of the big Canadian cannabis companies. Just a crazy idea, but unforeseen takeover attempts have happened before. Any thoughts?
Good luck to all!
Here is the printout of the 10-K (-12 loss vs -35 loss)
Revenues rising and expenses decreasing, heading in a more positive direction.
https://www.sec.gov/Archives/edgar/data/1648903/000147793219001279/fifg_10k.htm
10-K is out, 4 cents profit vs -23 loss
Wow, MDCL is on fire and it is only just beginning.
https://ih.advfn.com/stock-market/USOTC/medicine-man-technologies-inc-MDCL/stock-news/79712078/annual-report-10-k
Joshua Haupt released his form 4 today with the 400,000 shares he sold to Tigran Muradyan. I will say that it was a generous gesture, selling 200,000 at $1.00 and 200,000 at $1.50. Nice of him to give him that discount although Josh can require shares at $1.33 through the warrant exercise he has the option to. I will give Joshua much credit to not have the company do a share dilution by selling or issuing more shares to bring Tigran on board. This has to be a really good sign that Tigran is going to bring some special things to the table in the upcoming acquisitions. It is great to see many of you posting excellent information and doing the proper homework so we can be well informed. Thanks all for your efforts and looking forward to great times ahead.
Definitely looks like some kind of production news is around the corner. I like where this is headed. Low float and increasing revenue will make this soar. Good luck to all.
I wouldn't be surprised to see us close the week at a 52 week high.
An exciting time to be a MDCL shareholder. Looking forward to great things to come.
Jeans,
I just looked through the history of the company financials to view the transactions. Here is the link I was using.
https://www.otcmarkets.com/stock/MDCL/disclosure
So far an excellent day, keeping my fingers cross for a big move upward in the next few days.
Good luck to all.
Hoop
Yes, a form 4 should be forthcoming if he makes the purchase and any other of the board of directors doing so. But we won't be seeing that form until sometime into April if they did.
Drugdoctor... the board directors have an option for warrants to make a purchase at the end of this month (March) and the end of December. So that means he has to sell it now to take the money and make the transaction by the end of this week or it will cancel his opportunity. Past history has shown they have exercise their options/warrants in prior time periods.
I have no concrete knowledge of what they will do this time but only basing my thoughts on their past actions. If Josh took the money from his selling 200,000 shares at $1.80 and repurchased it at the warrant price of $1.33, then he would have 270,000 shares instead. Having 70,000 more shares while not dipping into your own wallet and knowing the potential future of what lies ahead, seems like a no brainer to me. We never like to see insiders selling at these low prices but I understand their actions.
Just imagine come December if this stock takes off soon what price the insiders can sell and buy back the stock at $1.33 and ring the register for themselves.
Just my thoughts, wishing us all a great year ahead for MDCL.
And since he and the other directors have been exercising their options/warrants when available, the most likely scenario is that he will be buying it back at the $1.33 warrant price. They have the option to purchase up to 3 million shares at $1.33 so it makes sense to sell at the higher price and buy back lower and pocket the difference. Just realize the positive action is that we have some real buyers with an appetite for shares out there slowly driving the price higher almost daily.
Good luck to all.